Under the terms of the partnership deal between the companies, Hyloris will receive a share on any revenues related to product, such as royalties, license fees, milestone payments,
The post AFT and Salus Pharmaceuticals sign agreement for pain treatment Maxigesic IV appeared first on Pharmaceutical Business review.